Efficacy and safety of insulin glargine/lixisenatide (iGlarLixi) fixed-ratio combination in older adults with type 2 diabetes. [electronic resource]
Producer: 20200702Description: 236-242 p. digitalISSN:- 1873-460X
- Aged
- Aged, 80 and over
- Blood Glucose -- analysis
- Body Weight
- Diabetes Mellitus, Type 2 -- blood
- Drug Combinations
- Fasting
- Gastrointestinal Diseases -- chemically induced
- Glycated Hemoglobin -- analysis
- Humans
- Hypoglycemic Agents
- Insulin Glargine -- administration & dosage
- Peptides -- administration & dosage
- Postprandial Period
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.